Armata Pharmaceuticals, Inc. announced last week that former White House COVID-19 response coordinator Dr. Deborah Birx has been appointed as its new Chief Executive Officer.
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology.
In an interview with Neil Cavuto, Birx admitted that she “knew” that COVID-19 vaccines “were not going to protect against infection” yet she pushed them anyway.
What could possibly Go wrong?